Federal contract award
W81K0223P0085
DIASORIN VARIOUS REAGENTS AND CONTROLS W/ USE OF LIAISON XL ANALYZER. BASE PERIOD: 1 AUG 2023 - 30 SEP 2023
Award details
Obligations, current value and potential value describe different measures; they are never added together.
| Field | Reported value |
|---|---|
| Agency | Department of Defense |
| Office | DEFENSE HEALTH AGENCY HCD WEST |
| NAICS | 325413 — In-Vitro Diagnostic Substance Manufacturing |
| PSC | 6550 — In Vitro Diagnostic Substances, Reagents, Test Kits and Sets |
| Parent award / vehicle | Not reported |
| Set-aside | NO SET ASIDE USED. |
| Pricing type | FIRM FIXED PRICE |
| Obligations | $256.9K |
| Current contract value | $363.4K |
| Potential contract value / ceiling | $363.4K |
| Start date | Aug 1, 2023 |
| Current end date | Sep 30, 2026 |
| Potential end date | Sep 30, 2027 |
| Latest award activity | Apr 2, 2026 |
| Source loaded | Sep 26, 2026 |
Funding and modification history
Showing the latest 13 of 13 loaded transactions. Negative values are deobligations.
| Date | Modification | Obligation change | Description |
|---|---|---|---|
| Jun 12, 2026 | P00012 | $0 | DIASORIN LIAISON XL ANALYZER REAGENTS AND CONTROLS |
| Apr 2, 2026 | P00011 | $0 | VARIOUS REAGENTS AND CONTROLS WITH THE USE OF DIASORIN LIAISON XL ANALYZER |
| Mar 23, 2026 | P00010 | $0 | VARIOUS REAGENTS AND CONTROLS WITH THE USE OF DIASORIN LIAISON XL ANALYZER |
| Feb 18, 2026 | P00009 | $6.7K | VARIOUS REAGENTS AND CONTROLS WITH THE USE OF DIASORIN LIAISON XL ANALYZER. |
| Nov 26, 2025 | P00008 | $99.8K | VARIOUS REAGENTS AND CONTROLS WITH THE USE OF DIASORIN LIAISON XL ANALYZER. |
| Jul 17, 2025 | P00007 | $0 | THE PURPOSE OF THIS ADMINISTRATIVE MODIFICATION IS TO EXERCISE OPTION 3 AND TO NOTIFY THE CONTRACTOR OF THE MIGRATION OF THIS AWARD TO THE ARMY CONTRACT WRITING SYSTEM (ACWS). |
| Feb 7, 2025 | P00006 | $0 | VARIOUS REAGENTS & CONTROLS W/ USE OF DIASORIN LIAISON LX ANALYZER. MOD P00006: UPDATE NO-COST ITEM ON ATTACHMENT 1 REFERENCED IN CLIN 2011, 3011, AND 4011. |
| Oct 28, 2024 | P00005 | $99.8K | VARIOUS REAGENTS & CONTROLS W/ USE OF DIASORIN LIAISON LX ANALYZER. MOD P00005: INCORPORATE FY25 FUNDS, ACWS VERBIAGE, AND RESTRUCTURE CLINS FOR OPTIONS 2, 3, AND 4. |
| May 7, 2024 | P00004 | $-67.5K | VARIOUS REAGENTS & CONTROLS W/ USE OF DIASORIN LIAISON LX ANALYZER. MOD P00004: DEOBLIGATE UNUSED FY24 FUNDS. |
| Apr 9, 2024 | P00003 | $0 | VARIOUS REAGENTS & CONTROLS W/ USE OF DIASORIN LIAISION LX ANALYZER. MOD P00003: EXERCISE OPTION 2: 1 OCT 2024 - 30 SEP 2025 |
| Oct 11, 2023 | P00002 | $99.8K | VARIOUS REAGENTS & CONTROLS W/ USE OF DIASORIN LIAISON XL ANALYZER. MOD P00002: INCORPORATE FY24 FUNDS FOR OPTION 1 (1 OCT 2023 - 30 SEP 2024) |
| Aug 16, 2023 | P00001 | $0 | VARIOUS REAGENTS & CONTROLS W/ USE OF DIASORIN LIAISON XL ANALYZER. MOD P00001: EXERCISE OPTION 1 (1 OCT 2023 - 30 SEP 2024) |
| Jul 24, 2023 | 0 | $18.2K | DIASORIN VARIOUS REAGENTS AND CONTROLS W/ USE OF LIAISON XL ANALYZER. BASE PERIOD: 1 AUG 2023 - 30 SEP 2023 |
Estimated positioning window
Nov 1, 2026 – Mar 30, 2027
80/100
Why this recompete signal
Contract timing and recorded acquisition signals at the time of calculation.
Stored score: 80/100. Available recorded signals: 75 points.
- Contract end 2027-09-30 (333 days from calculation)
- +35 points
- 93 historical awards in this buyer and category group
- +15 points
- 13 recorded award transactions
- +10 points
- Latest award action: 2026-04-02
- +5 points
- Parent award identifier recorded
- +0 points
- Solicitation identifier recorded
- +10 points
- Linked official forecast
- +0 points
- Calculated on
- 2026-11-01 10:17:53.997580+00:00
The historical group combines buyer, NAICS, and PSC. Multiple awards in this group do not by themselves establish repeated competitions.
Rule-based research score; it does not measure your chance of winning.
This older calculation does not retain a complete reproducible breakdown. Missing or changed inputs are not assigned invented points: Original award-value bonus input.
Recompete score calculated Nov 1, 2026.
Research next steps
- Check the linked forecast or SAM for a confirmed solicitation and current timing.
- Verify whether remaining options may extend performance beyond the current end date.
- Check the stated set-aside against the solicitation and current certifications.
- Review the award scope and buyer evidence before making a bid/no-bid decision.